Back to Search
ANDRIA BOLAND, PHARMD
PHARMD
Pharmacist
NPI: 1003429556Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Best supportive care in lung cancer trials is inadequately described: a systematic review.
PMID 19659663·Eur J Cancer Care (Engl)·2010
1-meta
Genome-wide association study identifies three loci associated with melanoma risk.
PMID 19578364·Nat Genet·2009
8-other
Comprehensive linkage and association analyses identify haplotype, near to the TNFSF15 gene, significantly associated with spondyloarthritis.
PMID 19543369·PLoS Genet·2009
8-other
Erlotinib for the treatment of relapsed non-small cell lung cancer.
PMID 19567213·Health Technol Assess·2009
8-other
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation.
PMID 19068191·Health Technol Assess·2009
1-meta
Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma.
PMID 19567210·Health Technol Assess·2009
8-other
The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review.
PMID 19114884·Crit Care Med·2009
1-meta
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.
PMID 18385738·Nature·2008
8-other
Egg box conformation of oligogalacturonides: the time-dependent stabilization of the elicitor-active conformation increases its biological activity.
PMID 18381977·Glycobiology·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9100 N SILVERBELL RD
TUCSON, AZ 85743 - Phone
- (520) 579-8935
Quick Facts
- NPI
- 1003429556
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile